Results 11 to 20 of about 536,398 (346)
Fibroblast Growth Factor 23 and Klotho in AKI. [PDF]
Seminars in Nephrology, 2019 Acute kidney injury (AKI) is associated with many of the same mineral metabolite abnormalities that are observed in chronic kidney disease. These include increased circulating levels of the osteocyte-derived, vitamin D-regulating hormone, fibroblast ...
Marta Christov +3 more
semanticscholar +3 more sources
Fibroblast Growth Factor 23 and Muscle Wasting: A Metabolic Point of View
Kidney International Reports, 2023 Protein energy wasting (PEW), mostly characterized by decreased body stores of protein and energy sources, particularly in the skeletal muscle compartment, is highly prevalent in patients with moderate to advanced chronic kidney disease (CKD). Fibroblast
Rengin Elsurer Afsar +2 more
semanticscholar +1 more source
Frontiers in Medicine, 2023 IntroductionA negative association between C-terminal fibroblast growth factor 23 (cFGF23) and hemoglobin (Hb) levels has been reported in patients with predialysis chronic kidney disease.
Yu-Wei Fang +9 more
doaj +1 more source
A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
BMC Nephrology, 2023 Background Patients who recover from acute kidney injury (AKI) have a 25% increase in the risk of chronic kidney disease (CKD) and a 50% increase in mortality after a follow-up of approximately 10 years.
Yinghui Lu +4 more
semanticscholar +1 more source
Direct and indirect effects of fibroblast growth factor 23 on the heart
Frontiers in Endocrinology, 2023 Fibroblast growth factor (FGF)23 is a bone-derived phosphotropic hormone that regulates phosphate and mineral homeostasis. Recent studies have provided evidence that a high plasma concentration of FGF23 is associated with cardiac disease, including left ...
T. Nakano +2 more
semanticscholar +1 more source
Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside
International Journal of Molecular Sciences, 2022 Osteoporosis is a chronic debilitating disease caused by imbalanced bone remodeling processes that impair the structural integrity of bone. Over the last ten years, the association between fibroblast growth factor 23 (FGF23) and osteoporosis has been ...
Wachiranun Sirikul +3 more
semanticscholar +1 more source
Kidney International, 2022 Fibroblast growth factor (FGF) 23 is a phosphate-regulating hormone that is elevated in patients with chronic kidney disease and associated with cardiovascular mortality.
Christopher Yanucil +18 more
semanticscholar +1 more source
Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease [PDF]
, 2012 Background: Uremic solute concentration increases as Glomerular Filtration Rate (GFR) declines. Weak associations were demonstrated between estimated GFR (eGFR) and the concentrations of several small water-soluble and protein-bound uremic solutes ...
Barreto, Daniela V +9 more
core +11 more sources
Biochemistry and Biophysics Reports, 2021 Fibroblast growth factor (FGF) 23 produced by the bone is the principal hormone to regulate serum phosphate level. Serum FGF23 needs to be tightly regulated to maintain serum phosphate in a narrow range.
Yuichi Takashi +8 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 Background and objective Growth differentiation factor-15 (GDF-15) and fibroblast growth factor-23 (FGF-23) are considered predictors of the incidence of cardiovascular diseases.
Ziqi Tan +7 more
semanticscholar +1 more source